The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline quickly condemned by abortion rights foes hoping to see the drug's use curtailed.
The FDA says its ongoing safety review of the nation's main abortion pill will continue into next year, a timeline quickly condemned by abortion rights foes hoping to see the drug's use curtailed.